AKT1 and breast cancer: Although the AKT signaling pathway is hyperactive in bone-metastasizing breast cancer [27,52], the isoform-specific effect of AKT on the formation of breast cancer bone metastases and on the vicious cycle of osteolysis remains unrevealed.